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history of hypertension or heart failure, weigh less; were less likely to use tobacco, have 
a history of bypass surgery; and were less likely to undergo coronary revascularization. 
(P<O.OOOl all). Increased time to revascularlzation. larger infarction size. and worse ejec- 
tion fraction on discharge were more predictive of stroke in men than in women (table). 
When multivariate analysis was performed of populations individually, these markers 
remained independently predictive in the male. but not female, population. Conclusion: 
Women are at significantly higher risk for in-hospital NHCVA following MI, which is not 
explained by their greater prevalence of other risk factors. 
Variable Males OR [95% 
(7 
Females OR [95% Cl] 
EF < .40 1.58 [1.37-I.831 1.34 [1.18-1.531 
Q waves on admission EKG 1.38[1.14-1.68] 1.04 [O 84-l ,281 
ST elevation > 6 leads 1.51 [1.08-2.111 0.91 [0.60-l ,381 
Door to primary PTCA > 120 minutes 2.71 [1.63-4.511 1.22 [0.78-l ,911 
Door to thrombolyiic > 45 minutes 1.74 [1.17-2.601 1.27 [0.80-2.011 
1146-113 Elevated Troponin I Is an Independent Prognostic 
Marker for Increased Mortality Even in Patients 
Hospitalized With Noncardiac Diagnoses 
Sved W. Bokhari, Curtiss T. Stinis, Jason A. Zell, Cyril Y. Leung, University of Califomia- 
Irvine Medical Center, Orange, CA 
Background: Numerous studies have shown Troponin I (Tnl) to be a valuable predictor 
of prognosis in acute coronary syndrome patients, but none has assessed the clinical 
significance of elevated Troponin I (~0.5 ngimL) in patients hospitalized with non-cardiac 
diagnoses. Methods: In a cross-sectional design, a total of 60 patients, 30 consecutive 
with elevated Troponin I (eTnl) and 30 consecutive with normal Troponin I (nTnl) hospi- 
talized with non-cardiac diagnoses were investigated. Prevalence Rate Ratio (PRR) was 
utilized to analyze all-cause mortality as the prlmaty end-point. Multinomial logistic 
regression analysis was utilized to adjust mortality data for variables that differed signifi- 
cantly between the two groups. Results: The mayor categories of the admitting diag- 
noses were pulmonary (eTnl = 8, nTnl = 9), sepsis (eTnl = 7, nTnl = l), neurological 
(eTnl = 6, nTnl = 9), gastrointestinal (eTnl = 7, nTnl = 6). and others (eTnl =2. nTnl = 5). 
There were no significant differences found between the two groups in terms of their total 
number of cardiac risk factors, previous history of coronary artery disease or coronary 
revascularization, baseline creatinine, hematocrit, cholesterol levels, and use of aspirin, 
beta-blockers, angiotensin converting enzyme Inhibitors, or statins. The eTnl group con- 
sisted of 57% males, compared to 67% males in the nTnl group (p = 0.01). Mean age in 
the eTnl group was 67.8 years compared to 59.8 years in the nTnl group (p = 0.047). Of 
the thirty patients with elevated Trill (mean = 2.10 +/- 0.52 SD), 12 (40%) died during 
index hospitalization as compared to zero deaths reported in patients with normal Tnl 
(mean = 0.04 +/- 0.007 SD), and this dlfference was significant (PRR = 2.7, 95% Cl = 
1.9-3.8, p < 0.0005). Despite differences in age and gender between the two groups, 
adjusted analysis revealed elevated Troponin I to be the only risk factor for mortality (p c 
0.0005 for Tnl; p = 0.9 for gender; p = 0.8 for age). Conclusion: We have shown for the 
first time that the elevated Tropomn I is an Independent prognostic marker for increased 
mortality even in the patients admitted with non-cardiac dlagnoses. There was a trend 
towards more patients with sepsis I” the elevated Troponin I group. 
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Rajendra H. Mehta, Cecelia K. Montoye. Jessica Faul, Dorothy Nagle, James Kure, 
Ethira] Raj, Peter Fattal, Mahamadali Amlani, Shire.2 Sherrif, Hameem Changhezi. 
Stephen Skorcz. Patricia Baker, Anthony DeFranco, Kim A. Eaale. on Behalf of ACC 
GAP Steering Committee, University of Michigan, Ann Arbor, Ml 
Background: Since tool use in GAP-Pilot Project resulted in high level of evidence. 
based therapies for pattents with acute myocardial infarctlon (Ml), we decided to test if 
major emphasis on process changes and tool use rather than focusing solely on improv- 
ing key Indicator rates would increase the use of evidence-based therapies. Methods 
The GAP-Flint-Saginaw Ml Initiative was modeled on GAP-Pilot Project in five area hos- 
pitals in Michigan with greater emphasis on tool use and continuous monitoring of tool 
use. This surveillance allowed for early identification of process changes, barriers, and 
reslstance to change. This in turn led to new rapld cycle plans to overcome barriers. Main 
outcome measures were Ml quality indicator use in pre- (l/1/01-6/30/01) and post- (12/ 
JACC March 19,2003 
15/01-3/31/02) measurement samples. Results: One or more tools were used in 93% of 
patients (standard orders=82%, critical pathways=79% and discharge document=44%). 
Indicator use is as shown (table). ‘=p<O.O5 compared to baseline. 
Indicators Baseline Remeasureme Remeasurement 
(1x523) nt (rl=499) (With tooI use) 
Withln 24 hours of hospital 
arrival 
Aspirin (%) 
Beta-blockers (%) 
LDL cholesterol measurement 
At discharge 
Asplrin (%) 
Beta-blockers (%) 
ACE inhibitors in patients with 
low LV dysfunction (%) 
Smoking cessation counseling 
(“~) 
Dietary counseling (%) 
Cholesterol lowering agents 
88.9 89.6 92.0 
71.8 71.6 72.0 
82.3 83.6 86.6 
78.8 90.9 93.4 
78.4 90.4 89.3 
69.2 88.8’ 93.7’ 
57.5 72.8’ 84.6’ 
78.1 
76.8 
88.8 95.4’ 
84.1 87.6 
Conclusions These data validate the results of GAP-Pilot Project that quality of MI care 
can be improved through emphasis on guideline-based tool use. Continuous monitoring 
of tool use and identifying/overcoming of barriers, lead to substantially higher tool use 
than observed in initial GAP project. Tool use is associated with higher adherence to key 
indicators, particularly key theraples at discharge. 
1147-93 Predictors of Treatment Delay in Patients With Acute 
Myocardial Infarction Undergoing Primary Angioplasty: 
An Analysis From the CADILLAC Trial 
Mark A. Turco, Martin Fahy, Roxana A. Mehran, Alexandra Lansky, Cindy L. Gr~nes, 
James E. Tcheng, Eulogio Garcia, Giulio Guagliumi, David A. Cox, Thomas D. Stuckey, 
Dawn E. Shaddinger, Gregg W. Stone, Center for Cardiac &Vascular Research and 
Washington Adventist Hospital, Takoma Park, MD, Cardiovascular Research Foundation 
and Lenox Hill Heart and Vascular Center, New York, NY 
Background: Delays in time to angioplasty after hospital arrival in patients (pts) under- 
going primary PCI for AMI have been associated with increased mortality in large data- 
bases. However, the inherent reasons and correlates for delay to angioplasty remain 
poorly understood. 
Methods: We analyzed the baseline demographic, angiographic, and procedure-related 
variables predictive of delays in door-to-balloon time (DB time) in the CADILLAC trial, in 
which 2,082 pts of any age with AMI onset cl2 hours (excluding shock) were randomized 
to PTCA vs stew, with vs without abciximab. 
Results: Median DB time was 120 minutes (interquartile range 90-l 62) for all pts. Statis- 
tically significant clinical predictors of delay > Phrs by univariate analysis included female 
gender (risk ratio 1.13, pcO.OOOl), circumflex infarction (RR 1.54, p<O.OOOl), insulin 
dependent diabetes (RR 2.22, p=O.O02), prior CABG (RR 3.28, p=O.O2), non-ST-eleva- 
tion Ml (RR 4.35. pcO.OOOl), 3 vessel disease (RR 1.30, p=O.O2), and delayed time to ER 
arrival (p=O.O003). Anglographic predictors of delay included pre-procedure TIMI- flow, 
small reference vessel diameter and larger initial MLD (all p<O.OOOl). Multtvariate predic- 
tors of delay using stepwise logistic regression Included non-LAD infarction (p=O.O4), 
female gender (p=O.O004), 3-vessel disease (p=O.O2), small reference vessel diameter 
(p<.OOOl), and larger initial MLD (p<O.OOOl). 
Conclusion: The time from hospital presentation to angioplasty IS >2hrs in 50% of pts 
with AMI undergoing contemporary interventional management. Predictors of delay to 
treatment after hospital arrival may be explained by atypical symptoms or indeterminate 
ECGs (female gender or LCX Ml), and less severe symptoms (smaller infarct vessel or 
patency of infarct vessel due to larger MLD). These data emphasize the need for aware- 
ness and expedited reperfusion pathways for patients at highest risk for delays to PCI. 
1147-94 Beneficial Effects of Direct Call to Emergency Medical 
Services on Time Delays and Management of Patients 
With Acute Myocardial Infarction: Real World Data From 
RICO Database 
Jean-Claude Beer, Gilles Dentan. Luc Janin-Manificat, Marianne Zeller, Yves Laurent, 
lsabelle Lhuillier, Jacques Ravisy Yves Cottin Jean-Eric Wolf, CHU Dijon, Dljon. France 2-1 
Background. Delayed access to medical care in patients with acute myocardial infarc- 
tion (AMI) increases myocardial damage. Only few studies have analysed the influence 
of direct call to emergency medical services (EMS) in patients with AMI. From the 
regional observatory of Ml (RICO) data base, we report the acute management in 
patients calling either EMS or other medical contact (OMC) as first medical seek after 
symptoms onset of Ml. Methods Data were prospectively collected from January to 
October 2001, in the 6 medical units in charge of Ml in the region of Cote d‘Or. Among 
the 322 patients included, only 57 (18%) directly called EMS after symptoms onset 
(group EMS) and 265 (82%) called another medical contact (group OMC). Results The 
baseline characteristics including age and risk factors were similar among the 2 groups 
of patients. Moreover, cardiovascular history was the same between the two groups, 
except for history of MI (21 % in EMS group vs 11 % I” OMC group, ~~0.05). The median 
tbmes from symptoms onset to first medical Intervention (48 vs 105 min, ~~0.02) and from 
